Faculty of Dentistry, University of Malaya, 50603, Kula Lumpur, Malaysia.
Faculty of Allied Health Sciences, International Islamic University Malaysia, 25200, Kuantan, Malaysia.
Biol Trace Elem Res. 2021 Feb;199(2):550-558. doi: 10.1007/s12011-020-02194-9. Epub 2020 May 26.
The current COVID-19 pandemic caused by SARS-CoV-2 has prompted investigators worldwide to search for an effective anti-viral treatment. A number of anti-viral drugs such as ribavirin, remdesivir, lopinavir/ritonavir, antibiotics such as azithromycin and doxycycline, and anti-parasite such as ivermectin have been recommended for COVID-19 treatment. In addition, sufficient pre-clinical rationale and evidence have been presented to use chloroquine for the treatment of COVID-19. Furthermore, Zn has the ability to enhance innate and adaptive immunity in the course of a viral infection. Besides, Zn supplement can favour COVID-19 treatment using those suggested and/or recommended drugs. Again, the effectiveness of Zn can be enhanced by using chloroquine as an ionophore while Zn inside the infected cell can stop SARS-CoV-2 replication. Given those benefits, this perspective paper describes how and why Zn could be given due consideration as a complement to the prescribed treatment of COVID-19.
由 SARS-CoV-2 引起的当前 COVID-19 大流行促使世界各地的研究人员寻找有效的抗病毒治疗方法。许多抗病毒药物,如利巴韦林、瑞德西韦、洛匹那韦/利托那韦、抗生素如阿奇霉素和强力霉素,以及驱虫药如伊维菌素,都被推荐用于 COVID-19 治疗。此外,已经提出了足够的临床前理论依据和证据,表明氯喹可用于治疗 COVID-19。此外,Zn 在病毒感染过程中具有增强先天和适应性免疫的能力。此外,Zn 补充剂可以促进使用那些建议和/或推荐药物治疗 COVID-19。同样,使用氯喹作为离子载体可以增强 Zn 的有效性,而感染细胞内的 Zn 可以阻止 SARS-CoV-2 的复制。鉴于这些好处,本观点文章描述了 Zn 如何以及为何可以作为 COVID-19 规定治疗的补充而得到适当考虑。